Table 1.

Identification and in vitro susceptibility testing of 17 Candida parapsilosis complex species from HUMAP-UFMS.

Isolates	Clinical specimens	Species	Minimal Inhibitory Concentrations (mg/L)
			AMB (S/I/R)	FLC (S/I/R)	VRC (S/I/R)	ANF (S/I/R)	MIF (S/I/R)
16 PC	CVC tip	C. parapsilosis	1.0 (S)	64 (R)	1.0 (R)	2.0 (I)	1.0 (I)
58 H	Blood	C. parapsilosis	0.5 (S)	32 (R)	0.5 (R)	1.0 (I)	1.0 (I)
87 H	Blood	C. parapsilosis	0.5 (S)	64 (R)	2.0 (R)	2.0 (I)	1.0 (I)
88 H	Blood	C. parapsilosis	1.0 (S)	64 (R)	1.0 (R)	2.0 (I)	1.0 (I)
137 H	Blood	C. parapsilosis	0.5 (S)	64 (R)	1.0 (R)	2.0 (I)	1.0 (I)
542 AMO	BMA	C. parapsilosis	1.0 (S)	64 (R)	1.0 (R)	2.0 (I)	1.0 (I)
340 PC	CVC tip	C. parapsilosis	1.0 (S)	64 (R)	1.0 (R)	2.0 (I)	1.0 (I)
422 PC	CVC tip	C. parapsilosis	1.0 (S)	4.0 (I)	0.06 (S)	2.0 (I)	1.0 (I)
29 H	Blood	C. parapsilosis	0.5 (S)	4.0 (I)	0.125 (S)	2.0 (I)	1.0 (I)
119 H	Blood	C. metapsilosis	0.25 (S)	2.0 (S)	0.03 (S)	0.25 (I)	0.25 (I)
188 H	Blood	C. parapsilosis	0.5 (S)	1.0 (S)	0.03 (S)	1.0 (I)	1.0 (I)
199 H	Blood	C. parapsilosis	0.25 (S)	1.0 (S)	0.03 (S)	2.0 (I)	1.0 (I)
65 H	Blood	C. orthopsilosis	0.5 (S)	0.5 (S)	0.03 (S)	0.25 (I)	0.25 (I)
191 H	Blood	C. orthopsilosis	0.5 (S)	0.5 (S)	0.016 (S)	0.5 (I)	0.25 (I)
559 H	Blood	C. parapsilosis	0.5 (S)	2.0 (S)	0.06 (S)	1.0 (I)	0.5 (I)
1131 PC	CVC tip	C. parapsilosis	0.5 (S)	32 (R)	0.5 (R)	2.0 (I)	1.0 (I)
662 H-II	Blood	C. parapsilosis	0.06 (S)	0.5 (S)	0.008 (S)	0.5 (I)	0.5 (I)

BMA, Bone marrow aspirate; CVC, Central venous catheter; AMB, Amphotericin B; ANF, Anidulafungin; CAF, Caspofungin; MIF, Micafungin; S, Susceptible; I, Intermediate; R, Resistant.